InsidersTradesSigma
Novo Nordisk A/S: management transactions · Denmark · Finanstilsynet DK
DK:novo-nordisk-asDK0060534915DK·Finanstilsynet DK
Browse the full management transaction log of Novo Nordisk A/S, a listed issuer based in Denmark. Shares are listed on DK DK, under the authority of Finanstilsynet DK. The latest transaction was disclosed on 12 May 2026 — Gift. Among the most active insiders: member/Executive/Associated Person. All data is accessible without an account.
206
Insider Decl.
0
Thresholds
€4m
39 ops.
Buy Volume
€6bn
56 ops.
Sell Volume
Financial data
Last declaration on 12 May 2026
Declarations206 total
Executives●Gift22DK FSA
DKK 1,96950 shares@ DKK 39.3812100.0% of flow
ShareOutside a trading venue
DK:1441704·
Executives●Sale19DK FSA
€1m26,246 shares@ €42.24020.0% of flow
ShareJANE STREET NETHERLANDS B.V.
DK:1419574·
Executives●Sale11DK FSA
€941,91922,000 shares@ €42.81450.0% of flow
ShareNasdaq Copenhagen
DK:1419156·
Executives●Other2DK FSA
01,085 shares0
ShareOutside a trading venue
DK:1418330·
Executives●Purchase2DK FSA
€269,8946,450 shares@ €41.84410.0% of flow
ShareNasdaq Copenhagen
DK:1401014·
Ideal exit: 14 Aug 2026 (T+270)
Executives●Other2DK FSA
018,634 shares0
ShareOutside a trading venue
DK:1399962·
Executives●Purchase2DK FSA
€44,518952 shares@ €46.76290.0% of flow
ShareNew York Stock Exchange
DK:1384043·
Ideal exit: 15 May 2026 (T+270)
Executives●Sale2DK FSA
€524,02812,000 shares@ €43.6690.0% of flow
ShareNasdaq Copenhagen
DK:1382865·
Executives●Sale2DK FSA
€1m28,710 shares@ €39.51640.0% of flow
ShareNasdaq Copenhagen
DK:1382513·
Executives●Sale2DK FSA
€3,14074 shares@ €42.42990.0% of flow
ShareCGET
DK:1382344·
Executives●Sale2DK FSA
€1m20,000 shares@ €59.61480.0% of flow
ShareNasdaq Copenhagen
DK:1362269·
Executives●Sale2DK FSA
€3m40,000 shares@ €83.13340.1% of flow
ShareNasdaq Copenhagen
DK:1341672·
Executives●Other2DK FSA
01,407 shares0
ShareOutside a trading venue
DK:1341302·
Executives●Purchase2DK FSA
€237,7122,500 shares@ €95.08490.0% of flow
ShareNew York Stock Exchange
DK:1328724·
Ideal exit: 15 Aug 2025 (T+270)
Executives●Purchase2DK FSA
€129,5341,300 shares@ €99.64140.0% of flow
ShareNew York Stock Exchange
DK:1327620·
Ideal exit: 9 Aug 2025 (T+270)
Executives●Other2DK FSA
018,634 shares0
ShareOutside a trading venue
DK:1327424·
Executives●Purchase2DK FSA
€141,3521,400 shares@ €100.96570.0% of flow
ShareNew York Stock Exchange
DK:1326827·
Ideal exit: 3 Aug 2025 (T+270)
Executives●Purchase2DK FSA
€130,8811,400 shares@ €93.48660.0% of flow
ShareNew York Stock Exchange
DK:1326582·
Ideal exit: 3 Aug 2025 (T+270)
Executives●Purchase2DK FSA
€1,54512.742 shares@ €121.24070.0% of flow
ShareNew York Stock Exchange
DK:1313875·
Ideal exit: 25 May 2025 (T+270)
Executives●Purchase2DK FSA
ShareNew York Stock Exchange
DK:1311855·
Ideal exit: 17 May 2025 (T+270)
Executives●Sale2DK FSA
€1m8,480 shares@ €119.99250.0% of flow
ShareNasdaq Copenhagen
DK:1310732·
Executives●Purchase7DK FSA
€1,31411 shares@ €119.41460.0% of flow
ShareNasdaq Copenhagen
DK:1310299·
Ideal exit: 6 May 2025 (T+270)
Executives●Purchase2DK FSA
€22,890208.385 shares@ €109.84410.0% of flow
ShareNew York Stock Exchange
DK:1310156·
Ideal exit: 4 May 2025 (T+270)
Executives●Purchase2DK FSA
€4037 shares@ €1.07190.0% of flow
ShareNew York Stock Exchange
DK:1309977·
Ideal exit: 5 May 2025 (T+270)
25 of 206 declarations
About Novo Nordisk A/S
Novo Nordisk A/S is a Danish pharmaceutical company specializing in the treatment of diabetes and other chronic diseases. It is listed on the Copenhagen Stock Exchange under the symbol NOVO.
